Yamo Pharmaceuticals Presents Results from Phase 2 Study of L1-79 in Adolescents and Young Adult Males with Autism Spectrum Disorder at INSAR 2019
May 14, 2019 08:01 ET
|
Yamo Pharmaceuticals
New York , May 14, 2019 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC, a clinical stage pharmaceutical company developing a novel therapy for autism spectrum disorder (ASD), announced the...
Cognoa Licenses Innovative Digital Therapeutic Technology
April 10, 2019 09:04 ET
|
Cognoa
PALO ALTO, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of digital behavioral health for children, today announces it has exclusively licensed technology from the...
Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices
February 06, 2019 09:04 ET
|
Cognoa
PALO ALTO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of digital behavioral health for children, today announces it has received Breakthrough Device designations...
Cognoa Selected by Cambia Health Solutions to Provide Support for Employees Raising Young Children
January 08, 2019 09:03 ET
|
Cognoa
PALO ALTO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Cognoa, a digital behavioral health company, announced today that Cambia Health Solutions, Inc. (Cambia) is incorporating Cognoa’s evidence-based...
LEARN Behavioral Announces Partnership with Cognoa to Empower Parents and Enable Earlier Diagnosis
November 15, 2018 09:04 ET
|
Cognoa
BALTIMORE, Md. and PALO ALTO, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- LEARN Behavioral, the leading network of providers serving children with autism and other special needs, today announces a...
Cognoa Demonstrates Advances of its AI-Based Technology for Identifying Autism in Children
August 27, 2018 13:49 ET
|
Cognoa
PALO ALTO, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Cognoa, a digital behavioral health company, today announces results from a clinical study of its second-generation AI based algorithms which...
SAP Teams with Cognoa to Bridge Gap in Healthcare for Employees Raising Young Children
June 12, 2018 09:03 ET
|
Cognoa
PALO ALTO, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Cognoa, a digital behavioral health company, today announces its partnership with SAP, a market leader in enterprise application software. More...
FDA Grants Fast Track Designation for Yamo Pharmaceutical’s L1-79 in Autism Spectrum Disorder
May 14, 2018 08:00 ET
|
Yamo Pharmaceuticals
New York, May 14, 2018 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC, a clinical stage pharmaceutical company developing a novel therapy for autism spectrum disorder (ASD), announced today that the...
Cognoa Hits Major Milestone Towards First AI-Based Autism Diagnostic
February 21, 2018 09:04 ET
|
Cognoa
PALO ALTO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cognoa, a company offering an AI-based platform for pediatric behavioral health diagnostics and digital therapeutics, announces that the U.S....
LifeLabs Launches Canada’s First Serving Customers with Autism Program
October 20, 2017 09:00 ET
|
LifeLabs
Toronto, ON, Oct. 20, 2017 (GLOBE NEWSWIRE) -- Ontarians with the Autism Spectrum Disorder (ASD) and their families can now receive specialized service through LifeLabs’ Serving Customers with...